Switzerland

Legal status	PERMISSIVE WITH RESTRICTIONS
Key organization	Federal Office of Public Health (FOPH)
Policy	hESC research is allowed with IVF embryos up to 7 days post-fertilisation, under strict conditions and with informed consent, or with cells imported specifically for research purposes. Cloning is prohibited. The creation of embryos for research is prohibited.
Regulations	Ordinance of 2 February 2005 on Research involving Embryonic Stem Cells (Stem Cell Research Ordinance, SCRO), RS 810.311: http://www.admin.ch/opc/en/classified-compilation/20042542/index.html
Legislation	Federal Act of 19 December 2003 on Research Involving Embryonic Stem Cells (Stem Cell Research Act, StRA), RS 810.13
Legislation Link	http://www.admin.ch/opc/en/classified-compilation/20022165/index.html
Embryonic stem cell research policy	hESc derivation and research is allowed with IVF surplus embryos with the approval of the Federal Office of Public Health (Federal Office).
Research with embryo	Research with embryos is allowed only with IVF surplus embryos. Embryo creation for research purposes is prohibited.
Embryo donation and cryopreservation	Embryo donation is prohibited.
Somatic cell nuclear transfer	SCNT is prohibited.
Genetic modification or selection	Interference with genetic material of human reproductive cells and embryos is prohibited.
Privacy and data protection	Federal Act of 30 September 2011 on Research Involving Human Beings (Human Research Act, HRA), RS 810.30, Articles 2, 3, 16, 17, 32 - 43, 45, 47, 49, 58, 59, and 63): http://www.admin.ch/opc/en/classified-compilation/20061313/index.html

Projects

• Accurate cell signatures for the advancement of personalized medicine
• BRAINTIME
• Deciphering the roles of transposable elements in 3D genome architecture and gene expression
• Great ape organoids to reconstruct uniquely human development
• HD-MEA-based Neuronal Assays and Network Analysis for Phenotypic Drug Screenings
• Mechanism of cone and ganglion cell death
• Multi-well High-resolution Electrophysiology Platform
• PKP2
• Reverse Scale-Crossing Effects In Biology

Provider

• Centre Hospitalier Universitaire Vaudois
• Centre Hospitalier Universitaire Vaudois - Laboratory of NeuroImmunology
• Centre Hospitalier Universitaire Vaudois - Laboratory of Neuroimmunology and Aging
• DiNAQOR AG
• ETH Zurich
• F. Hoffmann-La Roche Ltd
• Geneva University
• Geneva University - Embryonic stem cell Joint Team - Faculty of Medicine and University Hospitals
• Hopital Cantonal de Fribourg (HFR) - University of Fribourg
• Institute of Molecular and Clinical Ophthalmology Basel (IOB)
• Swiss Federal Institute of Technology
• University of Basel
• University of Basel - Embryonic stem cell Joint Team
• University of Zurich
• University of Zurich - iPSCore Zurich
• University of Zurich - Translational Molecular Psychiatry

hESC Cell lines

• UNIGEe001-A
• UBASe001-A
• UBASe002-A
• UBASe003-A
• CEBe033-A-1

hiPSC Cell lines

• EPFLi001-A
• EPFLi002-A
• EPFLi003-A
• EPFLi004-A
• EPFLi005-A
• EPFLi006-A
• UNIGEi001-A
• UNIGEi002-A
• UNIGEi003-A
• TMPi001-A
• TMPi001-B
• TMPi002-A
• TMPi002-B
• TMPi003-A
• TMPi003-B
• TMPi004-A
• TMPi004-B
• TMPi005-A
• TMPi005-B
• TMPi006-A
• TMPi006-B
• TMPi007-A
• TMPi007-B
• TMPi008-A
• TMPi009-A
• TMPi009-B
• CHUVi001-A
• IOBi001-A
• UNIGEi004-A
• LNISi001-A
• LNISi001-B
• LNISi002-A
• LNISi002-B
• LNISi003-A
• LNISi003-B
• LNISi004-A
• LNISi004-B
• LNISi005-A
• LNISi005-B
• LNISi006-A
• LNISi006-B
• LNISi007-A
• LNISi007-B
• LNISi008-A
• LNISi008-B
• LNISi009-A
• LNISi009-B
• LNISi010-A
• LNISi010-B
• LNISi011-A
• LNISi011-B
• LNISi012-A
• LNISi012-B
• LNISi013-A
• LNISi013-B
• LNISi014-A
• LNISi014-B
• LNISi015-A
• LNISi015-B
• LNISi016-A
• LNISi016-B
• LNISi017-A
• LNISi017-B
• QORi001-A
• QORi002-A
• PCIi033-A-1
• PCIi033-A-2
• PCIi033-A-3
• PCIi033-A-4
• QORi035-A
• QORi002-A-1
• TMPi008-B
• TMPi010-A
• TMPi010-B
• TMPi011-A
• TMPi011-B
• TMPi012-A
• TMPi012-B
• IPSCZHi001-A